A bold vision for the future of cell and gene therapy commercialization
Your CGT partner should be focused on enabling you to commercialize your treatment your way. That’s why InspiroGene offers a scalable, flexible suite of cell and gene therapy services supported by a dedicated team.
Not actual patients.
Backed by the experience of McKesson, InspiroGene is committed to leveraging our experience and deep understanding of the patient journey to create the best possible experience for all our customers.
Supported by 10+ years
of McKesson cell and gene therapy insights and expertise,
covering 95% of active CGT sites of care
InspiroGene was created to elevate the cell and gene therapy at every touchpoint. We’re more than a partner—we’re an ally, at your side, every day, to make sure that patients get the life-changing treatment they need. We’ve thoughtfully designed a configurable approach to bolster clear communication, improve responsiveness, and ensure a cohesive and consistent workflow.
A COMMITTED TEAM
that can be scaled to your needs – our team is your team
INDEPENDENT ENTITY (NON-PAYER-OWNED)
Fortune 10 company stability with established
relationships in top treating institutions
INDUSTRY-LEADING TECHNOLOGY AND PLATFORMS
designed to optimize the experience for manufacturers,
patients, payers, providers, and other stakeholders
